TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN RUXOLITINIB-TREATED PATIENTS WITH MYELOFIBROSIS WITH AND WITHOUT ANEMIA: A REAL-WORLD ANALYSIS

被引：0
|
作者：
Liu, T. [1 ]
Fillbrunn, M. [2 ]
Chen, J. [2 ]
Sajeev, G. [2 ]
Zhang, S. [3 ]
Signorovitch, J. [2 ]
机构：
[1] GSK plc, Philadelphia, PA USA
[2] Anal Grp Inc, Boston, MA USA
[3] GSK, Philadelphia, PA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S132 / S132
页数：1
相关论文
共 50 条
  • [21] Real-world treatment patterns and outcomes in patients with myelofibrosis treated with pacritinib in the United States
    Marrone, Michael
    Geller, Robert
    Oladapo, Abiola
    Suthar, Purvi
    Vasudevan, Anupama
    Vredenburg, Michael
    Zeng, Jia
    Rampal, Raajit
    Mascarenhas, John
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [22] Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors
    Huynh, Lynn
    Cai, Beilei
    Cheng, Mu
    Lax, Angie
    Lejeune, Dominique
    Duh, Mei S.
    Kim, Michelle K.
    PANCREAS, 2019, 48 (09) : 1126 - 1135
  • [23] Real-World Treatment Patterns and Healthcare Resource Utilization in Patients Prescribed Benztropine: A Claims Analysis From 2017-2020
    Chepke, Craig
    Cicero, Samantha
    Giraldo, Erika
    Hull, Michael
    Coyle, Katharine
    Yeaw, Jason
    Bron, Morgan
    CNS SPECTRUMS, 2023, 28 (02) : 249 - 250
  • [24] REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)
    Bhanegaonkar, A.
    Gauthier, G.
    Kim, R.
    Vekeman, F.
    Dea, K.
    Robitaille, M. N.
    Moyneur, E.
    Liu, F. X.
    VALUE IN HEALTH, 2020, 23 : S84 - S84
  • [25] Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
    Studer, Sean
    Hull, Michael
    Pruett, Janis
    Koep, Eleena
    Tsang, Yuen
    Drake, William, III
    PULMONARY CIRCULATION, 2018, 9 (01)
  • [26] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION IN URTICARIA PATIENTS NEWLY TREATED WITH OMALIZUMAB IN THE UNITED STATES
    Ke, X.
    Kavati, A.
    Wertz, D.
    Huang, Q.
    Wang, L.
    Willey, V. J.
    Stephenson, J. J.
    Ortiz, B.
    Paknis, B.
    Bernstein, J. A.
    Beck, L. A.
    VALUE IN HEALTH, 2017, 20 (05) : A161 - A161
  • [27] Real-World Use of Ruxolitinib in Patients with Myelofibrosis Who Had Anemia or Thrombocytopenia at US Community Practices
    Verstovsek, Srdan
    Yu, Jingbo
    Bland, Emily
    Schuler, Tammy
    Cordaro, Thomas
    Braunstein, Evan
    BLOOD, 2022, 140 : 8131 - 8132
  • [28] Ruxolitinib in myelofibrosis: a multicentre analysis of real-world patients in England, Northern Ireland and Wales
    Russell, J.
    Wright, C.
    Sparksman, D.
    Waddell, D.
    Daly, A.
    Fisken, R.
    Dicu, A.
    Cunningham, J.
    Docherty, S.
    Saha, C.
    Lentell, I.
    Lim, Y. J.
    Maw, K.
    Fowler, A.
    Knapper, S.
    Collins, A.
    Butt, N.
    Wadelin, F.
    Whalley, I.
    Gudgin, E.
    Godfrey, A.
    McMullin, M. F.
    Sadullah, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 81 - 82
  • [29] Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)
    Stein, Eytan M.
    Latremouille-Viau, Dominick
    Guerin, Annie
    Shi, Sherry
    Gagnon-Sanschagrin, Patrick
    Bonifacio, Gaetano
    Joseph, George J.
    BLOOD, 2016, 128 (22)
  • [30] Real-world healthcare resource utilization and treatment switching patterns in multiple sclerosis patients in a large US health plan
    Sanchirico, M.
    Ma, I.
    Caldwell-Tarr, A.
    Hashemi, L.
    Mudumby, P.
    Dufour, R.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 807 - 807
12345